AGENUS INC Other Current Assets
AGENUS INC (AGEN) had Other Current Assets of $2.02 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-07
- 2026-06-30: Other Assets, Current $2.02M.
- 2026-03-31: Other Assets, Current $2.04M.
- 2025-12-31: Other Assets, Current $1.09M.
- 2025-09-30: Other Assets, Current $1.20M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.02M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $2.04M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $1.09M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $1.20M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $1.76M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $2.42M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $2.42M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $2.81M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $3.35M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $3.13M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $2.37M 10-K · filed 2025-03-17 | |
| 2023-09-30 | $2.33M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.84M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $3.90M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $3.19M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $2.39M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $2.99M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $4.78M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $3.17M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $6.76M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $4.25M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $3.45M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $2.01M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $1.66M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.30M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $918.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.01M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $1.09M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.41M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.85M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $1.50M 10-K · filed 2020-03-16 | $1.50M 10-K · filed 2019-03-18 |
| 2018-09-30 | $811.92K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $649.55K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $597.94K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $1.08M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $1.24M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $950.62K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $634.95K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $838.54K 10-K · filed 2018-03-16 | |
| 2016-09-30 | $725.52K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $506.71K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $289.44K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $582.28K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $437.31K 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $618.88K 10-Q · filed 2015-08-03 | |
| 2015-03-31 | $747.44K 10-Q · filed 2015-05-01 | |
| 2014-12-31 | $639.96K 10-K · filed 2016-03-15 | $1.10M 10-K · filed 2015-03-16 |
| 2014-09-30 | $785.85K 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $2.99M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $443.80K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $163.00K 10-K · filed 2015-03-16 | |
| 2013-09-30 | $11.83K 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $56.03K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $64.95K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $32.16K 10-K · filed 2014-03-07 | |
| 2012-09-30 | $15.48K 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $218.08K 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $485.18K 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $699.79K 10-K · filed 2013-03-18 | |
| 2011-09-30 | $455.37K 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $422.20K 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $306.01K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |